Study on the influencing factors and predictive biomarkers of immune-related adverse events caused by tislelizumab in patients with malignant tumors
Zhu Hui, Yuan Yongfang, Xu Ying
Adverse Drug Reactions Journal . 2024, (1): 18 -24 .  DOI: 10.3760/cma.j.cn114015-20230803-00582